1. Home
  2. GH vs PJT Comparison

GH vs PJT Comparison

Compare GH & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.88

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$176.12

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
PJT
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
3.9B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GH
PJT
Price
$101.88
$176.12
Analyst Decision
Strong Buy
Hold
Analyst Count
21
3
Target Price
$79.19
$193.50
AVG Volume (30 Days)
2.4M
239.2K
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
0.57%
EPS Growth
N/A
72.84
EPS
N/A
6.53
Revenue
$902,569,000.00
$1,657,789,000.00
Revenue This Year
$34.72
$15.10
Revenue Next Year
$26.46
$11.10
P/E Ratio
N/A
$26.94
Revenue Growth
30.38
23.30
52 Week Low
$29.91
$119.76
52 Week High
$112.43
$190.28

Technical Indicators

Market Signals
Indicator
GH
PJT
Relative Strength Index (RSI) 56.90 60.04
Support Level $103.36 $163.95
Resistance Level $109.59 $171.01
Average True Range (ATR) 5.54 4.69
MACD -1.11 1.29
Stochastic Oscillator 42.83 97.86

Price Performance

Historical Comparison
GH
PJT

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

Share on Social Networks: